![Douglas Cowart](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Douglas Cowart
Gründer bei Cardioxyl Pharmaceuticals LLC
Aktive Positionen von Douglas Cowart
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Cardioxyl Pharmaceuticals LLC
![]() Cardioxyl Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardioxyl Pharmaceuticals, Inc. discovers and develops therapies and technologies for the treatment of cardiovascular diseases. It offers nitroxyl therapeutics, including CXL-1020, a nitroxyl donor compound for the intravenous treatment of acute decompensated heart failure and nitroxyl donor compounds for unmet medical needs in other cardiovascular indications. The company was founded by Vincent J. Kalish and Douglas Cowart in 2005 and is headquartered in Chapel Hill, NC. | Gründer | 20.01.2010 | - |
General Counsel | 20.01.2010 | - | |
Nometics, Inc.
![]() Nometics, Inc. Pharmaceuticals: MajorHealth Technology Nometics, Inc. operates as a specialty pharmaceutical company. It focuses on the treatment of cancer through the restoration of the nitric oxide signaling pathway. The company is headquartered in Toronto, Canada. | General Counsel | - | - |
Karriereverlauf von Douglas Cowart
Ehemalige bekannte Positionen von Douglas Cowart
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Medifacts International Corp.
![]() Medifacts International Corp. Miscellaneous Commercial ServicesCommercial Services Medifacts International Corp. provides clinical research services to pharmaceutical, biotech & medical device companies that are developing therapeutic drugs and products. Its services include ECG, holter, ABPM, automated BP, telemedicine, pulse wave analysis, and other related services. The company was founded in 1985 by Sandra S. Garrett and is headquartered in Rockville, MD. | Geschäftsführer | 01.01.1998 | 01.01.2002 |
Leadiant Biosciences, Inc.
![]() Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences, Inc. operates as a research-based pharmaceutical company. It develops and commercializes medicines for rare diseases. The company was founded in 1989 by Claudio Cavazza and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | - | - |
Otsuka America Pharmaceutical, Inc.
![]() Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Otsuka America Pharmaceutical, Inc. manufactures and supplies pharmaceutical products. It develops drugs for neuroscience, cardiovascular, and gastrointestinal treatments. The company was founded in 1989 and is headquartered in Rockville, MD. | Corporate Officer/Principal | 01.01.1998 | 01.01.2002 |
Cortria Corp.
![]() Cortria Corp. Pharmaceuticals: MajorHealth Technology Cortria Corp. operates as a clinical-stage pharmaceutical company that focuses on developing medicines to fight cardiovascular disease. Its product is used for the treatment of dyslipidemia, an atherogenic disorder characterized by abnormal lipid levels in the bloodstream. The company was founded in August 2005 and is headquartered in Needham, MA. | General Counsel | - | - |
Ausbildung von Douglas Cowart
University of Georgia | Undergraduate Degree |
Medical University of South Carolina | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 8 |
Kanada | 2 |
Operativ
General Counsel | 3 |
Corporate Officer/Principal | 2 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 6 |
Consumer Services | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 6 |
---|---|
Cortria Corp.
![]() Cortria Corp. Pharmaceuticals: MajorHealth Technology Cortria Corp. operates as a clinical-stage pharmaceutical company that focuses on developing medicines to fight cardiovascular disease. Its product is used for the treatment of dyslipidemia, an atherogenic disorder characterized by abnormal lipid levels in the bloodstream. The company was founded in August 2005 and is headquartered in Needham, MA. | Health Technology |
Medifacts International Corp.
![]() Medifacts International Corp. Miscellaneous Commercial ServicesCommercial Services Medifacts International Corp. provides clinical research services to pharmaceutical, biotech & medical device companies that are developing therapeutic drugs and products. Its services include ECG, holter, ABPM, automated BP, telemedicine, pulse wave analysis, and other related services. The company was founded in 1985 by Sandra S. Garrett and is headquartered in Rockville, MD. | Commercial Services |
Otsuka America Pharmaceutical, Inc.
![]() Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Otsuka America Pharmaceutical, Inc. manufactures and supplies pharmaceutical products. It develops drugs for neuroscience, cardiovascular, and gastrointestinal treatments. The company was founded in 1989 and is headquartered in Rockville, MD. | Health Technology |
Cardioxyl Pharmaceuticals LLC
![]() Cardioxyl Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardioxyl Pharmaceuticals, Inc. discovers and develops therapies and technologies for the treatment of cardiovascular diseases. It offers nitroxyl therapeutics, including CXL-1020, a nitroxyl donor compound for the intravenous treatment of acute decompensated heart failure and nitroxyl donor compounds for unmet medical needs in other cardiovascular indications. The company was founded by Vincent J. Kalish and Douglas Cowart in 2005 and is headquartered in Chapel Hill, NC. | Health Technology |
Leadiant Biosciences, Inc.
![]() Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences, Inc. operates as a research-based pharmaceutical company. It develops and commercializes medicines for rare diseases. The company was founded in 1989 by Claudio Cavazza and is headquartered in Gaithersburg, MD. | Health Technology |
Nometics, Inc.
![]() Nometics, Inc. Pharmaceuticals: MajorHealth Technology Nometics, Inc. operates as a specialty pharmaceutical company. It focuses on the treatment of cancer through the restoration of the nitric oxide signaling pathway. The company is headquartered in Toronto, Canada. | Health Technology |
- Börse
- Insiders
- Douglas Cowart
- Erfahrung